Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

Featured Articles | Featured Partners | Videos | Industry News | Events

January 22, 2026

Newsletter Sponsor

Integrated Solutions for Ultra-High Potent OSD Products
As pipelines push into ultra-high potency, conventional HPAPI capability is no longer enough. PCI Pharma Services supports oral solid dose manufacturing at validated OEB 5–6 levels, with infrastructure, analytics, and controls designed for sub-microgram OELs. Our integrated model also includes clinical and commercial packaging to support development and manufacturing programmes, helping sponsors manage risk, reduce complexity, and progress ultra-potent assets with confidence.

	Industry News

	bioMérieux Acquires Accellix bioMérieux announced the acquisition of Accellix, a company specializing in rapid, automated flow ... read more »

	Rentschler Biopharma Appoints Head of Business Development U.S. Rentschler Biopharma SE announced that Detra Glinatsis has rejoined the company as Head of Business ... read more »

	Charles River Enters Manufacturing Collaboration with Gazi University Charles River Laboratories International and Gazi University Faculty of Medicine, announced a gene ... read more »

	Syngene International Extends Research Collaboration with BMS until 2035 Syngene International announced the extension of its long-standing strategic collaboration with ... read more »

	Featured Articles

		Quality: The Gold Standard for CDMOs - No Exceptions, No Compromises In today’s hyper-competitive pharmaceutical landscape, innovation, speed-to-market and cost control usually take the spotlight when selecting a contract development and manufacturing organization (... read more »

		An Interview With Andreas Eschbach How has AI acceptance evolved in the pharmaceutical sector, and what strategies have been most effective in overcoming resistance to AI adoption? read more »

	Featured Video

Watch Video: Emerging Trends in the CDMO Landscape with Bend Bioscience
Bend Bioscience Adapts to Emerging Trends in the CDMO Landscape. An Interview with Michael Grass, Head of Innovation read more »

Watch Video: IMA at CPHI Frankfurt 2025 - TILE-X Gloveless, small-batch RTU fill-finish solution
In this video, from CPHI Frankfurt 2025 - learn about the TILE-X Gloveless, small-batch RTU fill-finish solution from IMA. read more »

	Whitepapers

		3D Screen Printing: A Scalable Innovation for Advanced Drug Formulations This article examines the transformative potential of 3D screen printing technology in pharmaceutical manufacturing. Unlike traditional 3D printing ... read more »

		Overcoming Barriers to Patient Adherence with a Novel Dosage Form To make administration of an effective drug treatment easier for patients with hand tremors or swallowing difficulties, Adare Pharma Solutions ... read more »

	More Services

Pharmaceutical Manufacturing Services Learn More
Analytical Testing Services Learn More
Analytical Method Development & Validation Learn More

	Service Directory

Pharmaceutical Laboratory Instrument Services Search More

Pharmaceutical Genomic Services / Genetic Analysis Services (DNA / RNA / Viral) Search More

	Events

Clinical Trials Innovation Programme 2026 - EU
Nice, France – 02/10/2026
The Clinical Trials Innovation Programme 2026 brings together leading minds to transform how trials are designed, managed, and executed. event details »

Webinar: Validation & Engineering Convergence: How Digital, Cloud, and AI Are Reshaping Processes
Virtual – February 11, 2026
Preparing teams for evolving validation, automation, and system modernization expectations. event details »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA